PEAK6 Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$5.96M Buy
47,200
+31,400
+199% +$3.82M 0.03% 689
2018
Q1
$1.71M Sell
15,800
-6,100
-28% -$675K 0.01% 1508
2017
Q4
$2.4M Buy
21,900
+2,100
+11% +$210K 0.01% 1265
2017
Q3
$1.95M Buy
19,800
+2,500
+14% +$242K 0.01% 1400
2017
Q2
$1.75M Buy
17,300
+4,500
+35% +$485K 0.01% 1460
2017
Q1
$1.48M Buy
12,800
+6,300
+97% +$732K 0.01% 1359
2016
Q4
$780K Sell
6,500
-11,900
-65% -$1.32M 0.01% 2095
2016
Q3
$2.07M Buy
18,400
+16,900
+1,127% +$1.95M 0.02% 1265
2016
Q2
$186K Buy
+1,500
New +$181K ﹤0.01% 3202
2016
Q1
Sell
-6,500
Closed -$707K 4456
2015
Q4
$707K Sell
6,500
-20,200
-76% -$2.31M ﹤0.01% 2259
2015
Q3
$2.67M Buy
26,700
+9,500
+55% +$1.03M 0.01% 1341
2015
Q2
$1.96M Buy
17,200
+14,600
+562% +$1.77M 0.01% 1486
2015
Q1
$272K Sell
2,600
-58,900
-96% -$6.28M ﹤0.01% 3145
2014
Q4
$7.4M Buy
61,500
+26,600
+76% +$3.49M 0.06% 441
2014
Q3
$5.11M Buy
34,900
+34,200
+4,886% +$5.28M 0.04% 653
2014
Q2
$117K Buy
+700
New +$125K ﹤0.01% 3622
2013
Q3
Sell
-5,800
Closed -$880 5137
2013
Q2
$880 Buy
+5,800
New +$822K ﹤0.01% 2250

Other funds holding CLB

PEAK6 Group's CLB Position: Q2 2018 in Review

PEAK6 Group increased its Core Laboratories (CLB) stake by 66% in Q2 2018, buying an estimated $74.5K and bringing the position to 1,544 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

PEAK6 Group first reported a position in CLB in Q4 2013 and has held it in 13 quarters since. The position peaked at $2.46M in Q3 2014. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

  • PEAK6 Group held 1,544 shares of Core Laboratories worth $195K as of Q2 2018.
  • PEAK6 Group bought 612 Core Laboratories shares in Q2 2018, an estimated $74.5K.
  • Core Laboratories made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3356 holding.
  • PEAK6 Group first reported a position in Core Laboratories in Q4 2013 and has held it in 13 quarters since.
  • PEAK6 Group's Core Laboratories position peaked at $2.46M in Q3 2014.
  • 374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.